Gintautas Vainorius
1PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Sep 09, 2024
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.Birgit Wilding, Lydia Woelflingseder, Anke Baum
Pageof 1
Frequent Collaborators
1 joint publications
Birgit Wilding
1 joint publications
Lydia Woelflingseder
1 joint publications
Anke Baum
1 joint publications
Krzysztof Chylinski
1 joint publications
Neil Gibson
1 joint publications
Irene C Waizenegger
1 joint publications
Daniel Gerlach
1 joint publications
Martin Augsten
1 joint publications
Fiona Spreitzer
1 joint publications
Yukina Shirai
